Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Taber

Showing results (21-30 of 209) with videos related to

Pageof 21
Sort By:
Therapeutic Drug Monitoring|January 9, 2020
Dosing Requirements of Extended-Release Tacrolimus (Astagraf XL) in African American Kidney Transplant Recipients Converted from Immediate-Release Tacrolimus (AAAKTRS)James N Fleming, Maria A Posadas Salas, David J Taber
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 17, 2018
The effect of Share 35 on biliary complications: An interrupted time series analysisJ N Fleming, D J Taber, D Axelrod, et al.
Pharmacotherapy|August 26, 2018
Investigating the Potential for Bias When Using a Widely Accepted Medication Adherence Measure to Predict MortalityRalph C Ward, David J Taber, Robert Neal Axon, et al.
The Annals of Pharmacotherapy|June 12, 2014
Cardiovascular Drug Shortages: Predominant Etiologies, Clinical Implications, and Management StrategiesBarbara S Wiggins, Jean Nappi, Christopher R Fortier, et al.
Therapeutic Drug Monitoring|January 28, 2003
Evaluation of estimated and measured creatinine clearances for predicting the pharmacokinetics of vancomycin in adult liver transplant recipientsDavid J Taber, Amy L Fann, Greg Malat, et al.
Transplantation|March 5, 2019
Long-term Assessment of NSAID Prescriptions and Potential Nephrotoxicity Risk in Adult Kidney Transplant RecipientsJordan M Chiasson, Cory E Fominaya, Mulugeta Gebregziabher, et al.
The Annals of Pharmacotherapy|March 1, 2014
Lithium dosing equations: are they accurate?Taylor A Nichols, Shannon J Drayton, Jeffrey Borckardt, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|May 22, 2016
Utility of the Surgical Apgar Score in Kidney Transplantation: Is it Feasible to Predict ICU Admission, Hospital Readmission, Length of Stay, and Cost in This Patient Population?William D Stoll, David J Taber, Seth J Palesch, et al.
Therapeutic Drug Monitoring|February 9, 2021
Etiologies and Outcomes Associated With Tacrolimus Levels Out of a Typical Range That Lead to High Variability in Kidney Transplant RecipientsDavid J Taber, Jason Hirsch, Alison Keys, et al.
JMIR Research Protocols|March 4, 2018
Improving Transplant Medication Safety Through a Pharmacist-Empowered, Patient-Centered, mHealth-Based Intervention: TRANSAFE Rx Study ProtocolJames N Fleming, Frank Treiber, John McGillicuddy, et al.
Pageof 21

Showing results (21-30 of 209) with videos related to

Sort By:
Pageof 21
Therapeutic Drug Monitoring|January 9, 2020
Dosing Requirements of Extended-Release Tacrolimus (Astagraf XL) in African American Kidney Transplant Recipients Converted from Immediate-Release Tacrolimus (AAAKTRS)James N Fleming, Maria A Posadas Salas, David J Taber
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 17, 2018
The effect of Share 35 on biliary complications: An interrupted time series analysisJ N Fleming, D J Taber, D Axelrod, et al.
Pharmacotherapy|August 26, 2018
Investigating the Potential for Bias When Using a Widely Accepted Medication Adherence Measure to Predict MortalityRalph C Ward, David J Taber, Robert Neal Axon, et al.
The Annals of Pharmacotherapy|June 12, 2014
Cardiovascular Drug Shortages: Predominant Etiologies, Clinical Implications, and Management StrategiesBarbara S Wiggins, Jean Nappi, Christopher R Fortier, et al.
Therapeutic Drug Monitoring|January 28, 2003
Evaluation of estimated and measured creatinine clearances for predicting the pharmacokinetics of vancomycin in adult liver transplant recipientsDavid J Taber, Amy L Fann, Greg Malat, et al.
Transplantation|March 5, 2019
Long-term Assessment of NSAID Prescriptions and Potential Nephrotoxicity Risk in Adult Kidney Transplant RecipientsJordan M Chiasson, Cory E Fominaya, Mulugeta Gebregziabher, et al.
The Annals of Pharmacotherapy|March 1, 2014
Lithium dosing equations: are they accurate?Taylor A Nichols, Shannon J Drayton, Jeffrey Borckardt, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|May 22, 2016
Utility of the Surgical Apgar Score in Kidney Transplantation: Is it Feasible to Predict ICU Admission, Hospital Readmission, Length of Stay, and Cost in This Patient Population?William D Stoll, David J Taber, Seth J Palesch, et al.
Therapeutic Drug Monitoring|February 9, 2021
Etiologies and Outcomes Associated With Tacrolimus Levels Out of a Typical Range That Lead to High Variability in Kidney Transplant RecipientsDavid J Taber, Jason Hirsch, Alison Keys, et al.
JMIR Research Protocols|March 4, 2018
Improving Transplant Medication Safety Through a Pharmacist-Empowered, Patient-Centered, mHealth-Based Intervention: TRANSAFE Rx Study ProtocolJames N Fleming, Frank Treiber, John McGillicuddy, et al.
Pageof 21